← feed

Is NCT04358770 results overdue?

Yes — results are overdue. Primary completion was 2018-04-27; the FDAAA-801 reporting deadline (2019-04-27) passed 2658 days ago and no results are posted on ClinicalTrials.gov.

Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream

NCT IDNCT04358770 ↗
SponsorSun Pharmaceutical Industries, Inc. (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-04-27 (ACTUAL)
Reporting deadline2019-04-27 (completion + 365d)
Days overdue2658
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 83907989448e544f… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT04358770. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →